Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) Net Margin (2019 - 2025)

Pulmonx has reported Net Margin over the past 7 years, most recently at 64.91% for Q3 2025.

  • Quarterly Net Margin rose 451.0% to 64.91% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 61.9% through Sep 2025, up 1017.0% year-over-year, with the annual reading at 67.3% for FY2024, 2129.0% up from the prior year.
  • Net Margin was 64.91% for Q3 2025 at Pulmonx, down from 63.69% in the prior quarter.
  • Over five years, Net Margin peaked at 55.44% in Q4 2024 and troughed at 147.07% in Q1 2022.
  • The 5-year median for Net Margin is 84.57% (2023), against an average of 88.79%.
  • The largest YoY upside for Net Margin was 21926bps in 2021 against a maximum downside of -5224bps in 2021.
  • A 5-year view of Net Margin shows it stood at 94.81% in 2021, then grew by 2bps to 92.64% in 2022, then rose by 22bps to 72.16% in 2023, then grew by 23bps to 55.44% in 2024, then decreased by -17bps to 64.91% in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Net Margin are 64.91% (Q3 2025), 63.69% (Q2 2025), and 63.95% (Q1 2025).